Humasis Co., Ltd.

New drug, TPN, Fixed Dose Combination

  • Название:
  • Humasis Co., Ltd.
  • Сайт:
  • Humasis Co., Ltd.
  • Address:

  • 37, Gunpocheondansaneop 2-ro, Gunpo-si, Gyeonggi-do, Korea

  • Telephone:

  • +82-31-8085-6200

  • Email:

  • marketing@humasis.com

О компании

Since founded in 2000 as a company specializing in Rapid Test, Humasis Co., Ltd. has been focusing on one field of Point-of-Care Testing (POCT). As an R&D company based on the will, autonomy, and creativity to develop new technologies that can accurately and quickly analyze the causes of diseases in humans using biotechnology, we are to create a human-centered company that values the development of both individuals and companies participating in this.

Продукция

All product list

Humasis COVID-19 Ag Test

The Humasis COVID-19 Ag Test is an in vitro diagnostic test based on lateral flow chromatographic immunoassay intended for the qualitative detection of antigen-specific to SARS-CoV-2 in human nasopharyngeal swab specimens. The test can aid in the diagnosis of COVID-19 infection in a fast and accurate method. Its procedure is simple, easy, and fast. The result is shown within 15 minutes. No additional instrument is needed.

Тест Humasis COVID-19 IgG/IgM Test

The Humasis COVID-19 IgG/IgM Test is an in vitro diagnostic test based on lateral flow chromatographic immunoassay intended for the qualitative detection of IgG and IgM antibodies specific to SARS-CoV-2 in human whole blood, plasma, or serum. The test can aid in the diagnosis of COVID-19 infection in a fast and accurate method. It requires only 10uL of whole blood, plasma, or serum. The result is shown within 15 minutes.

Отправить сообщение